The DOI matches its Crossref record; 235 of the 235 references it cites were found in a registry or an index.
Intestinal Barrier in Human Health and Disease
Open accessAbstract
The intestinal mucosa provides a selective permeable barrier for nutrient absorption and protection from external factors. It consists of epithelial cells, immune cells and their secretions. The gut microbiota participates in regulating the integrity and function of the intestinal barrier in a homeostatic balance. Pathogens, xenobiotics and food can disrupt the intestinal barrier, promoting systemic inflammation and tissue damage. Genetic and immune factors predispose individuals to gut barrier dysfunction, and changes in the composition and function of the gut microbiota are central to this process. The progressive identification of these changes has led to the development of the concept of ‘leaky gut syndrome’ and ‘gut dysbiosis’, which underlie the relationship between intestinal barrier impairment, metabolic diseases and autoimmunity. Understanding the mechanisms underlying this process is an intriguing subject of research for the diagnosis and treatment of various intestinal and extraintestinal diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819 · cited 2×
“A high fat diet (HFD) promotes gut leakiness through dysbiosis, since antibiotic treatment has been shown to be effective in improving intestinal permeability and glucose homeostasis in HFD-fed mice [128].”
BackgroundRichness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Nitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 3×
“In experimental models, after DSS administration, SLE-predisposed mice showed an elevated inflammatory response secondary to increased intestinal permeability, with production of autoantibodies and the spread of systemic inflammation [110].”
BackgroundChronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Gut microbiota, metabolites and host immunity
Rooks, M. G., & Garrett, W. S. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.42 · Cited by 3,409
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1237-9 · Cited by 3,143 · cited 2×
“A major variability in the gut microbiota composition has also been reported, together with a lower abundance of Subdoligranulum species, the clinical relevance of which is under investigation [93].”
BackgroundZelante, T., Iannitti, R. G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D’Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.003 · Cited by 2,614 · cited 1×
“22, a cytokine that can enhance mucosal immunity in mice and restore epithelial integrity [43,235,236].”
BackgroundThe impact of dietary fiber on gut microbiota in host health and disease
Makki, K., Deehan, E. C., Walter, J., & Bäckhed, F. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.012 · Cited by 2,517
Gut–brain axis: How the microbiome influences anxiety and depression
Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460
Signaling to NF-κB by Toll-like receptors
Kawai, T., & Akira, S. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.09.002 · Cited by 2,388
Role of the gut microbiota in nutrition and health
Valdes, A. M., Walter, J., Segal, E., & Spector, T. D. (2018) · BMJ · doi:10.1136/bmj.k2179 · Cited by 2,375 · cited 1×
“The gut microbiota is composed of 100 trillion microorganisms [21].”
BackgroundA microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340
Round, J. L., & Mazmanian, S. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909122107 · Cited by 2,233
A comprehensive definition for metabolic syndrome
Huang, P. L. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001180 · Cited by 2,214
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803124105 · Cited by 2,200
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice
Chassaing, B., Aitken, J. D., Malleshappa, M., & Vijay‐Kumar, M. (2014) · Current Protocols in Immunology · doi:10.1002/0471142735.im1525s104 · Cited by 2,090
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Regulation of short-chain fatty acid production
Macfarlane, S., & Macfarlane, G. T. (2003) · Proceedings of the Nutrition Society · doi:10.1079/pns2002207 · Cited by 1,939
Regional specialization within the intestinal immune system
Mowat, A. M., & Agace, W. W. (2014) · Nature Reviews Immunology · doi:10.1038/nri3738 · Cited by 1,756
Regulation of inflammation by short chain fatty acids
Vinolo, M. A. R., Rodrigues, H. G., Nachbar, R. T., & Curi, R. (2011) · Nutrients · doi:10.3390/nu3100858 · Cited by 1,724
Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications
Davani-Davari, D., Negahdaripour, M., Karimzadeh, I., Seifan, M., Mohkam, M., Masoumi, S., Berenjian, A., & Ghasemi, Y. (2019) · Foods · doi:10.3390/foods8030092 · Cited by 1,716
Zhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708 · cited 1×
“concomitant HFD and ameliorated by antibiotics administration or weight loss, the latter associated with a marked reduction in blood ethanol concentration [183,184].”
BackgroundRole of gut microbiota in type 2 diabetes pathophysiology
Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D. B., Morgun, A., & Shulzhenko, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.051 · Cited by 1,708
Important Flavonoids and Their Role as a Therapeutic Agent
Ullah, A., Munir, S., Badshah, S. L., Khan, N., Ghani, L., Poulson, B. G., Emwas, A.-H., & Jaremko, M. (2020) · Molecules · doi:10.3390/molecules25225243 · Cited by 1,696 · cited 1×
“Flavonoids are natural phenolic substances found in plants and associated with various health properties in humans [229].”
BackgroundZhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., Wu, X., Li, J., Tang, L., Li, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3914 · Cited by 1,690
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
The roles of TLRs, RLRs and NLRs in pathogen recognition
Kawai, T., & Akira, S. (2009) · International Immunology · doi:10.1093/intimm/dxp017 · Cited by 1,670
Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk
Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P., & Hu, F. B. (2010) · Circulation · doi:10.1161/circulationaha.109.876185 · Cited by 1,641
Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria
Macpherson, A. J., & Uhr, T. (2004) · Science · doi:10.1126/science.1091334 · Cited by 1,584 · cited 1×
“Immunoglobulin A is the first serum immunoglobulin, participates in mucosal immunity [46], and regulates inflammatory responses against commensal bacteria, avoiding dysbiosis [47,48].”
BackgroundMucus barrier, mucins and gut microbiota: the expected slimy partners?
Paone, P., & Cani, P. D. (2020) · Gut · doi:10.1136/gutjnl-2020-322260 · Cited by 1,578
Inflammatory bowel disease: Pathogenesis
Zhang, Y.-Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.91 · Cited by 1,507
Gut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503
An insight into gut microbiota and its functionalities
Adak, A., & Khan, M. R. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2943-4 · Cited by 1,485
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483 · cited 8×
“In addition, some microbial species such as Bacteroides fragilis can promote Foxp3+ regulatory T-cell expansion and IL-10 secretion through the expression of polysaccharide A (PSA), a capsular carbohydrate recognized for its immunomodulatory and anti-inflammatory properties in experimental models of colitis [36–38].”
InfluentialThe gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480
Kim, S., Kwon, S.-H., Kam, T.-I., Panicker, N., Karuppagounder, S. S., Lee, S., Lee, J. H., Kim, W. R., Kook, M., Foss, C. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.035 · Cited by 1,397 · cited 1×
“In addition, recent findings support the hypothesis that a-synuclein is formed in the gut and then transferred to the central nervous system via the vagus nerve [114].”
BackgroundGut microbiota in the pathogenesis of inflammatory bowel disease
Nishida, A., Inoue, R., Inatomi, O., Bamba, S., Naito, Y., & Andoh, A. (2018) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-017-0813-5 · Cited by 1,377
Proton pump inhibitors affect the gut microbiome
Imhann, F., Bonder, M. J., Vich Vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E. F., Jankipersadsing, S. A., Cenit, M. C., Harmsen, H. J. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310376 · Cited by 1,371 · cited 1×
“The impairment of the acid barrier exposes the intestinal tract to infections with various microorganisms [73] and modifies the gut microbiota, reducing its diversity and promoting the proliferation of oral bacteria in the small intestine [74].”
BackgroundPelaseyed, T., Bergström, J. H., Gustafsson, J. K., Ermund, A., Birchenough, G. M. H., Schütte, A., van der Post, S., Svensson, F., Rodríguez‐Piñeiro, A. M., Nyström, E. E. L., et al. (2014) · Immunological Reviews · doi:10.1111/imr.12182 · Cited by 1,363
The intestinal epithelial barrier: a therapeutic target?
Odenwald, M. A., & Turner, J. R. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.169 · Cited by 1,288
The intestinal barrier: a fundamental role in health and disease
Vancamelbeke, M., & Vermeire, S. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1343143 · Cited by 1,287
Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease
Palm, N. W., de Zoete, M. R., Cullen, T. W., Barry, N. A., Stefanowski, J., Hao, L., Degnan, P. H., Hu, J., Peter, I., Zhang, W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.006 · Cited by 1,286 · cited 2×
“As emerged from an experimental study on mice, IgA coating is also a mechanism of recognition of possible colitogenic bacteria from the gut microbiota [49].”
BackgroundHELLER, F., FLORIAN, P., BOJARSKI, C., RICHTER, J., CHRIST, M., HILLENBRAND, B., MANKERTZ, J., GITTER, A., BURGEL, N., & FROMM, M. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.002 · Cited by 1,230
Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., Bettencourt, R., Highlander, S. K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.001 · Cited by 1,123
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., White, M. B., Monteith, P., Noble, N. A., Unser, A. B., Daita, K., Fisher, A. R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.019 · Cited by 1,099 · cited 1×
“Intercurrent events such as infections or hepatic decompensation are associated with major changes in the gut microbiota [150].”
BackgroundNew evidences on the altered gut microbiota in autism spectrum disorders
Strati, F., Cavalieri, D., Albanese, D., De Felice, C., Donati, C., Hayek, J., Jousson, O., Leoncini, S., Renzi, D., Calabrò, A., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0242-1 · Cited by 1,040
Fasano, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2008 · Cited by 1,003
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children
Kang, D.-W., Park, J. G., Ilhan, Z. E., Wallstrom, G., LaBaer, J., Adams, J. B., & Krajmalnik-Brown, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068322 · Cited by 976 · cited 1×
“Microbiota studies in these patients have shown an inverse relationship between microbiota diversity and neurological impairment [118], and a modification of Firmicutes/Bacteroidetes ratio, caused by a reduction of Bacteroidetes bacteria [119].”
BackgroundNext-generation probiotics: the spectrum from probiotics to live biotherapeutics
O’Toole, P. W., Marchesi, J. R., & Hill, C. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.57 · Cited by 971 · cited 1×
“Next-generation probiotics are a potential new class of therapeutic drugs consisting of microorganisms not previously used, such Akkermansia, Bacteroides, and Faecalibacterium, deriving from gut microbiota [203].”
BackgroundHyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., et al. (2018) · Science · doi:10.1126/science.aar3318 · Cited by 942
Buie, T., Campbell, D. B., Fuchs, G. J., Furuta, G. T., Levy, J., VandeWater, J., Whitaker, A. H., Atkins, D., Bauman, M. L., Beaudet, A. L., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-1878c · Cited by 872 · cited 1×
“Children with autism spectrum disorders (ASD) often experience intestinal symptoms, such as constipation, abdominal pain and diarrhea [117].”
BackgroundBacteriophage targeting of gut bacterium attenuates alcoholic liver disease
Duan, Y., Llorente, C., Lang, S., Brandl, K., Chu, H., Jiang, L., White, R. C., Clarke, T. H., Nguyen, K., Torralba, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1742-x · Cited by 844
Pathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M., & Geuking, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 805
Tobacco smoking and cancer: a brief review of recent epidemiological evidence
Sasco, A. J., Secretan, M. B., & Straif, K. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.07.998 · Cited by 804
Enteric dysbiosis associated with a mouse model of alcoholic liver disease
Yan, A. W., Fouts, D. E., Brandl, J., Stärkel, P., Torralba, M., Schott, E., Tsukamoto, H., Nelson, K. E., Brenner, D. A., & Schnabl, B. (2011) · Hepatology · doi:10.1002/hep.24018 · Cited by 791
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Kakiyama, G., Pandak, W. M., Gillevet, P. M., Hylemon, P. B., Heuman, D. M., Daita, K., Takei, H., Muto, A., Nittono, H., Ridlon, J. M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.003 · Cited by 781
Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Casella, G., Drew, J. C., Ilonen, J., Knip, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025792 · Cited by 778
Dietary prebiotics: current status and new definition
Gibson, G. R., Scott, K. P., Rastall, R. A., Tuohy, K. M., Hotchkiss, A., Dubert-Ferrandon, A., Gareau, M., Murphy, E. F., Saulnier, D., Loh, G., et al. (2010) · Food Science & Technology Bulletin: Functional Foods · doi:10.1616/1476-2137.15880 · Cited by 778
Michielan, A., & D’Incà, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/628157 · Cited by 709
Vinolo, M. A. R., Rodrigues, H. G., Hatanaka, E., Sato, F. T., Sampaio, S. C., & Curi, R. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.07.009 · Cited by 708
A gut-vascular barrier controls the systemic dissemination of bacteria
Spadoni, I., Zagato, E., Bertocchi, A., Paolinelli, R., Hot, E., Di Sabatino, A., Caprioli, F., Bottiglieri, L., Oldani, A., Viale, G., et al. (2015) · Science · doi:10.1126/science.aad0135 · Cited by 695
Mouries, J., Brescia, P., Silvestri, A., Spadoni, I., Sorribas, M., Wiest, R., Mileti, E., Galbiati, M., Invernizzi, P., Adorini, L., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.005 · Cited by 688
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571731 · Cited by 673
Tight Junction Structure and Function Revisited
Otani, T., & Furuse, M. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.08.004 · Cited by 665
Ponziani, F. R., Bhoori, S., Castelli, C., Putignani, L., Rivoltini, L., Del Chierico, F., Sanguinetti, M., Morelli, D., Paroni Sterbini, F., Petito, V., et al. (2019) · Hepatology · doi:10.1002/hep.30036 · Cited by 654
Self-citationGuarner, F. (1998) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(97)00136-0 · Cited by 637
Profile of the gut microbiota of adults with obesity: a systematic review
Crovesy, L., Masterson, D., & Rosado, E. L. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0607-6 · Cited by 604
Yoon, H. S., Cho, C. H., Yun, M. S., Jang, S. J., You, H. J., Kim, J.-H., Han, D., Cha, K. H., Moon, S. H., Lee, K., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00880-5 · Cited by 602
Natural food additives: Quo vadis?
Carocho, M., Morales, P., & Ferreira, I. C. F. R. (2015) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2015.06.007 · Cited by 585
Probiotic Bacterium Prevents Cytokine-induced Apoptosis in Intestinal Epithelial Cells
Yan, F., & Polk, D. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207050200 · Cited by 562
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis
Nowarski, R., Jackson, R., Gagliani, N., de Zoete, M. R., Palm, N. W., Bailis, W., Low, J. S., Harman, C. C. D., Graham, M., Elinav, E., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.072 · Cited by 558
Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella Pneumoniae
Yuan, J., Chen, C., Cui, J., Lu, J., Yan, C., Wei, X., Zhao, X., Li, N., Li, S., Xue, G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.018 · Cited by 548
Intestinal barrier: An interface between health and disease
FARHADI, A., BANAN, A., FIELDS, J., & KESHAVARZIAN, A. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03032.x · Cited by 530
Roles and regulation of the mucus barrier in the gut
Cornick, S., Tawiah, A., & Chadee, K. (2015) · Tissue Barriers · doi:10.4161/21688370.2014.982426 · Cited by 526
Anderson, R. C., Cookson, A. L., McNabb, W. C., Park, Z., McCann, M. J., Kelly, W. J., & Roy, N. C. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-316 · Cited by 510
Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair
Chen, M.-K., & Guilarte, T. R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.12.004 · Cited by 506
Bile Acids Induce Inflammatory Genes in Hepatocytes
Allen, K., Jaeschke, H., & Copple, B. L. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.026 · Cited by 501
Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes
Wang, X., Ota, N., Manzanillo, P., Kates, L., Zavala-Solorio, J., Eidenschenk, C., Zhang, J., Lesch, J., Lee, W. P., Ross, J., et al. (2014) · Nature · doi:10.1038/nature13564 · Cited by 500
Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders
Fiorentino, M., Sapone, A., Senger, S., Camhi, S. S., Kadzielski, S. M., Buie, T. M., Kelly, D. L., Cascella, N., & Fasano, A. (2016) · Molecular Autism · doi:10.1186/s13229-016-0110-z · Cited by 494 · cited 1×
“This study could explain a possible pathological link between intestinal disorders and the development of autism [122].”
BackgroundHost–microbiota interactions in immune-mediated diseases
Ruff, W. E., Greiling, T. M., & Kriegel, M. A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0367-2 · Cited by 487
Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease
Kesika, P., Suganthy, N., Sivamaruthi, B. S., & Chaiyasut, C. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118627 · Cited by 479
Lerner, A., & Matthias, T. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.01.009 · Cited by 475
Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease
Shannon, K. M., Keshavarzian, A., Mutlu, E., Dodiya, H. B., Daian, D., Jaglin, J. A., & Kordower, J. H. (2012) · Movement Disorders · doi:10.1002/mds.23838 · Cited by 469
The role of IL-22 in intestinal health and disease
Keir, M. E., Yi, T., Lu, T. T., & Ghilardi, N. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20192195 · Cited by 464
Ki, S. H., Park, O., Zheng, M., Morales-Ibanez, O., Kolls, J. K., Bataller, R., & Gao, B. (2010) · Hepatology · doi:10.1002/hep.23837 · Cited by 434
Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis
Costello, M., Ciccia, F., Willner, D., Warrington, N., Robinson, P. C., Gardiner, B., Marshall, M., Kenna, T. J., Triolo, G., & Brown, M. A. (2015) · Arthritis & Rheumatology · doi:10.1002/art.38967 · Cited by 432
Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice
Yang, J.-Y., Lee, Y.-S., Kim, Y., Lee, S.-H., Ryu, S., Fukuda, S., Hase, K., Yang, C.-S., Lim, H. S., Kim, M.-S., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.42 · Cited by 432
Medical records documentation of constipation preceding Parkinson disease: A case-control study
Savica, R., Carlin, J. M., Grossardt, B. R., Bower, J. H., Ahlskog, J. E., Maraganore, D. M., Bharucha, A. E., & Rocca, W. A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c34af5 · Cited by 430
Human gut-associated lymphoid tissues (GALT); diversity, structure, and function
Mörbe, U. M., Jørgensen, P. B., Fenton, T. M., von Burg, N., Riis, L. B., Spencer, J., & Agace, W. W. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00389-4 · Cited by 424
Targeting the gut-liver axis in liver disease
Wiest, R., Albillos, A., Trauner, M., Bajaj, J. S., & Jalan, R. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.007 · Cited by 419
Elevated endotoxin levels in non-alcoholic fatty liver disease
Harte, A. L., da Silva, N. F., Creely, S. J., McGee, K. C., Billyard, T., Youssef-Elabd, E. M., Tripathi, G., Ashour, E., Abdalla, M. S., Sharada, H. M., et al. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-15 · Cited by 390
Wang, L., Fouts, D. E., Stärkel, P., Hartmann, P., Chen, P., Llorente, C., DePew, J., Moncera, K., Ho, S. B., Brenner, D. A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.003 · Cited by 389
The gut–joint axis in rheumatoid arthritis
Zaiss, M. M., Joyce Wu, H.-J., Mauro, D., Schett, G., & Ciccia, F. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00585-3 · Cited by 389
Importance and regulation of the colonic mucus barrier in a mouse model of colitis
Petersson, J., Schreiber, O., Hansson, G. C., Gendler, S. J., Velcich, A., Lundberg, J. O., Roos, S., Holm, L., & Phillipson, M. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00422.2010 · Cited by 385
Effect of Metformin on Metabolic Improvement and Gut Microbiota
Lee, H., & Ko, G. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.01357-14 · Cited by 385
Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage
Keshavarzian, A. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00678-9 · Cited by 384
Macrophage polarization and meta-inflammation
Li, C., Xu, M. M., Wang, K., Adler, A. J., Vella, A. T., & Zhou, B. (2018) · Translational Research · doi:10.1016/j.trsl.2017.10.004 · Cited by 370
Yamagata, K., Daitoku, H., Shimamoto, Y., Matsuzaki, H., Hirota, K., Ishida, J., & Fukamizu, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314322200 · Cited by 364
Alcohol and Gut-Derived Inflammation
Bishehsari, F. (2017) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v38.2.02 · Cited by 364
Hendrikx, T., Duan, Y., Wang, Y., Oh, J.-H., Alexander, L. M., Huang, W., Stärkel, P., Ho, S. B., Gao, B., Fiehn, O., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317232 · Cited by 361
Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity
Kinashi, Y., & Hase, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.673708 · Cited by 356
Myosin light chain kinase: pulling the strings of epithelial tight junction function
Cunningham, K. E., & Turner, J. R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06526.x · Cited by 345 · cited 1×
“SCFAs, particularly sodium butyrate, can promote TJ reassembly by regulating AMP-activated protein kinase (AMPK) activation and phosphorylation of myosin II regulatory light chain (MLC2), reinforcing the intestinal epithelial barrier [27,28].”
BackgroundPathophysiology of Portal Hypertension
Iwakiri, Y. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.12.001 · Cited by 337
Rahman, K., Desai, C., Iyer, S. S., Thorn, N. E., Kumar, P., Liu, Y., Smith, T., Neish, A. S., Li, H., Tan, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.022 · Cited by 334
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
Oh, T. G., Kim, S. M., Caussy, C., Fu, T., Guo, J., Bassirian, S., Singh, S., Madamba, E. V., Bettencourt, R., Richards, L., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.005 · Cited by 334
Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
Bajaj, J. S., Betrapally, N. S., Hylemon, P. B., Heuman, D. M., Daita, K., White, M. B., Unser, A., Thacker, L. R., Sanyal, A. J., Kang, D. J., et al. (2015) · Hepatology · doi:10.1002/hep.27819 · Cited by 325
Increased Intestinal Permeability Is Associated With Later Development of Crohn’s Disease
Turpin, W., Lee, S.-H., Raygoza Garay, J. A., Madsen, K. L., Meddings, J. B., Bedrani, L., Power, N., Espin-Garcia, O., Xu, W., Smith, M. I., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.005 · Cited by 318
Watts, T., Berti, I., Sapone, A., Gerarduzzi, T., Not, T., Zielke, R., & Fasano, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500178102 · Cited by 313
Peyer's patches: organizing B‐cell responses at the intestinal frontier
Reboldi, A., & Cyster, J. G. (2016) · Immunological Reviews · doi:10.1111/imr.12400 · Cited by 311
Dodiya, H. B., Forsyth, C. B., Voigt, R. M., Engen, P. A., Patel, J., Shaikh, M., Green, S. J., Naqib, A., Roy, A., Kordower, J. H., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.12.012 · Cited by 305
Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis
Man, S. M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0054-1 · Cited by 302
The intestinal barrier, an arbitrator turned provocateur in IBD
Mehandru, S., & Colombel, J.-F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00399-w · Cited by 299
Gut Microbiota in Human Systemic Lupus Erythematosus and a Mouse Model of Lupus
Luo, X. M., Edwards, M. R., Mu, Q., Yu, Y., Vieson, M. D., Reilly, C. M., Ahmed, S. A., & Bankole, A. A. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.02288-17 · Cited by 290
Keita, Å. V., & Söderholm, J. D. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01498.x · Cited by 286
Trifan, A., Stanciu, C., Girleanu, I., Stoica, O. C., Singeap, A. M., Maxim, R., Chiriac, S. A., Ciobica, A., & Boiculese, L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i35.6500 · Cited by 286
Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk
Hartmann, P., Seebauer, C. T., & Schnabl, B. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12704 · Cited by 282
L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases
Rhoads, J. M., Argenzio, R. A., Chen, W., Rippe, R. A., Westwick, J. K., Cox, A. D., Berschneider, H. M., & Brenner, D. A. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.5.g943 · Cited by 278
The subgingival microbiome of clinically healthy current and never smokers
Mason, M. R., Preshaw, P. M., Nagaraja, H. N., Dabdoub, S. M., Rahman, A., & Kumar, P. S. (2015) · The ISME Journal · doi:10.1038/ismej.2014.114 · Cited by 276
Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications
Krishna Rao, R., & Samak, G. (2013) · Current Nutrition & Food Science · doi:10.2174/1573401311309020004 · Cited by 266
Tight Junctions as a Key for Pathogens Invasion in Intestinal Epithelial Cells
Paradis, T., Bègue, H., Basmaciyan, L., Dalle, F., & Bon, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052506 · Cited by 266
Rios, D., Wood, M. B., Li, J., Chassaing, B., Gewirtz, A. T., & Williams, I. R. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.121 · Cited by 264
Suriano, F., Vieira-Silva, S., Falony, G., Roumain, M., Paquot, A., Pelicaen, R., Régnier, M., Delzenne, N. M., Raes, J., Muccioli, G. G., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01097-8 · Cited by 263
Somasundaram, Sigthorsson, Simpson, Watts, Jacob, Tavares, Rafi, Roseth, Foster, Price, et al. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00723.x · Cited by 262
Llorente, C., Jepsen, P., Inamine, T., Wang, L., Bluemel, S., Wang, H. J., Loomba, R., Bajaj, J. S., Schubert, M. L., Sikaroodi, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00796-x · Cited by 257 · cited 1×
“This process is called “gut oralization”, and is associated with bacterial translocation and liver damage in alcoholic and metabolic liver diseases [75].”
BackgroundLee, S., Yun, Y., Kim, S., Lee, E.-J., Chang, Y., Ryu, S., Shin, H., Kim, H.-L., Kim, H.-N., & Lee, J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7090282 · Cited by 255
Sorribas, M., Jakob, M. O., Yilmaz, B., Li, H., Stutz, D., Noser, Y., de Gottardi, A., Moghadamrad, S., Hassan, M., Albillos, A., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.017 · Cited by 253
Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments
de Mattos, B. R. R., Garcia, M. P. G., Nogueira, J. B., Paiatto, L. N., Albuquerque, C. G., Souza, C. L., Fernandes, L. G. R., Tamashiro, W. M. D. S. C., & Simioni, P. U. (2015) · Mediators of Inflammation · doi:10.1155/2015/493012 · Cited by 251
Ciccia, F., Bombardieri, M., Principato, A., Giardina, A., Tripodo, C., Porcasi, R., Peralta, S., Franco, V., Giardina, E., Craxi, A., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24389 · Cited by 241
Tryptophan Dietary Impacts Gut Barrier and Metabolic Diseases
Taleb, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02113 · Cited by 236
Role of flavonoids in intestinal tight junction regulation
Suzuki, T., & Hara, H. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.08.001 · Cited by 231
Patel, V. C., Lee, S., McPhail, M. J. W., Da Silva, K., Guilly, S., Zamalloa, A., Witherden, E., Støy, S., Manakkat Vijay, G. K., Pons, N., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.09.010 · Cited by 227
Verbeke, L., Farre, R., Verbinnen, B., Covens, K., Vanuytsel, T., Verhaegen, J., Komuta, M., Roskams, T., Chatterjee, S., Annaert, P., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.10.009 · Cited by 225
The potential role of vitamin D supplementation as a gut microbiota modifier in healthy individuals
Singh, P., Rawat, A., Alwakeel, M., Sharif, E., & Al Khodor, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-77806-4 · Cited by 225
Role of the Gut Microbiome in Modulating Arthritis Progression in Mice
Liu, X., Zeng, B., Zhang, J., Li, W., Mou, F., Wang, H., Zou, Q., Zhong, B., Wu, L., Wei, H., et al. (2016) · Scientific Reports · doi:10.1038/srep30594 · Cited by 222
Benjamin, J. L., Hedin, C. R. H., Koutsoumpas, A., Ng, S. C., McCarthy, N. E., Prescott, N. J., Pessoa-Lopes, P., Mathew, C. G., Sanderson, J., Hart, A. L., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21864 · Cited by 221
Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice
Mutlu, E. A., Engen, P. A., Soberanes, S., Urich, D., Forsyth, C. B., Nigdelioglu, R., Chiarella, S. E., Radigan, K. A., Gonzalez, A., Jakate, S., et al. (2011) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-8-19 · Cited by 220
Herath, M., Hosie, S., Bornstein, J. C., Franks, A. E., & Hill-Yardin, E. L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00248 · Cited by 213
Tanase, D. M., Gosav, E. M., Neculae, E., Costea, C. F., Ciocoiu, M., Hurjui, L. L., Tarniceriu, C. C., Maranduca, M. A., Lacatusu, C. M., Floria, M., et al. (2020) · Nutrients · doi:10.3390/nu12123719 · Cited by 207
Ye, D., Li, F. Y. L., Lam, K. S. L., Li, H., Jia, W., Wang, Y., Man, K., Lo, C. M., Li, X., & Xu, A. (2012) · Gut · doi:10.1136/gutjnl-2011-300269 · Cited by 206 · cited 9×
“E. coli and K. pneumoniae are able to ferment dietary carbohydrates into ethanol, which, upon reaching the liver through the portal circulation, causes oxidative stress and may promote the development of NASH.”
BackgroundInfluentialBile Acids and FXR: Novel Targets for Liver Diseases
Stofan, M., & Guo, G. L. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00544 · Cited by 197
Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes
Massier, L., Chakaroun, R., Tabei, S., Crane, A., Didt, K. D., Fallmann, J., von Bergen, M., Haange, S.-B., Heyne, H., Stumvoll, M., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320118 · Cited by 194 · cited 1×
“In patients with type 2 diabetes mellitus (T2DM), hyperglycemia promotes a proinflammatory condition that is related to intestinal permeability, bacterial translocation, and metabolic endotoxemia [127,128].”
BackgroundBeyond Heat Stress: Intestinal Integrity Disruption and Mechanism-Based Intervention Strategies
Lian, P., Braber, S., Garssen, J., Wichers, H. J., Folkerts, G., Fink-Gremmels, J., & Varasteh, S. (2020) · Nutrients · doi:10.3390/nu12030734 · Cited by 194
Microbiome, Metabolome and Inflammatory Bowel Disease
Ahmed, I., Roy, B., Khan, S., Septer, S., & Umar, S. (2016) · Microorganisms · doi:10.3390/microorganisms4020020 · Cited by 193
M Cells: Intelligent Engineering of Mucosal Immune Surveillance
Dillon, A., & Lo, D. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01499 · Cited by 193
Jubair, W. K., Hendrickson, J. D., Severs, E. L., Schulz, H. M., Adhikari, S., Ir, D., Pagan, J. D., Anthony, R. M., Robertson, C. E., Frank, D. N., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40490 · Cited by 190
Update on FXR Biology: Promising Therapeutic Target?
Han, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072069 · Cited by 185
Haynes, T. E., Li, P., Li, X., Shimotori, K., Sato, H., Flynn, N. E., Wang, J., Knabe, D. A., & Wu, G. (2009) · Amino Acids · doi:10.1007/s00726-009-0243-x · Cited by 183
Paneth cells: their role in innate immunity and inflammatory disease
Elphick, D. A., & Mahida, Y. R. (2005) · Gut · doi:10.1136/gut.2005.068601 · Cited by 183
Prebiotics in Chronic Intestinal Inflammation
Looijer–Van Langen, M. A. C., & Dieleman, L. A. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20737 · Cited by 183
Vijay-Kumar, M., Chassaing, B., Kumar, M., Baker, M. T., & Singh, V. K. (2014) · Biomedical Journal · doi:10.4103/2319-4170.130922 · Cited by 182
Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases
Battistini, C., Ballan, R., Herkenhoff, M. E., Saad, S. M. I., & Sun, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010362 · Cited by 182
Gut-Liver Axis and Sensing Microbes
Szabo, G., Bala, S., Petrasek, J., & Gattu, A. (2010) · Digestive Diseases · doi:10.1159/000324281 · Cited by 179
Nagpal, R., Newman, T. M., Wang, S., Jain, S., Lovato, J. F., & Yadav, H. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3462092 · Cited by 177
Maccioni, L., Gao, B., Leclercq, S., Pirlot, B., Horsmans, Y., De Timary, P., Leclercq, I., Fouts, D., Schnabl, B., & Stärkel, P. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1782157 · Cited by 174 · cited 7×
“Recently, OCA has been shown to restore GVB integrity and reduce bacterial translocation in experimental models [223,224].”
BackgroundInfluentialHigh-affinity monoclonal IgA regulates gut microbiota and prevents colitis in mice
Okai, S., Usui, F., Yokota, S., Hori-i, Y., Hasegawa, M., Nakamura, T., Kurosawa, M., Okada, S., Yamamoto, K., Nishiyama, E., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.103 · Cited by 172
Atkinson, K. J., & Rao, R. K. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.6.g1280 · Cited by 171
Vitamin D, vitamin D receptor and tissue barriers
Zhang, Y.-G., Wu, S., & Sun, J. (2013) · Tissue Barriers · doi:10.4161/tisb.23118 · Cited by 167
The “Leaky Gut”: Tight Junctions but Loose Associations?
Hollander, D., & Kaunitz, J. D. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05777-2 · Cited by 165
Miao, W., Wu, X., Wang, K., Wang, W., Wang, Y., Li, Z., Liu, J., Li, L., & Peng, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101696 · Cited by 164
Vemuri, R., Shankar, E. M., Chieppa, M., Eri, R., & Kavanagh, K. (2020) · Microorganisms · doi:10.3390/microorganisms8040483 · Cited by 162
Roberts, C. L., Rushworth, S. L., Richman, E., & Rhodes, J. M. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.01.004 · Cited by 161
Multiple NSAID-Induced Hits Injure the Small Intestine: Underlying Mechanisms and Novel Strategies
Boelsterli, U. A., Redinbo, M. R., & Saitta, K. S. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs310 · Cited by 159
Next-generation probiotics: a promising approach towards designing personalized medicine
Singh, T. P., & Nataraj, B. H. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1902940 · Cited by 157
Ahmadi, S., Razazan, A. P., Nagpal, R., Jain, S., Wang, B., Mishra, S. P., Wang, S., Justice, J. N., Ding, J., McClain, D. A., et al. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa056 · Cited by 154
Altered Peripheral and Central Inflammatory Responses in a Mouse Model of Autism
Lucchina, L., & Depino, A. M. (2013) · Autism Research · doi:10.1002/aur.1338 · Cited by 153
Association Between Exercise-Induced Hyperthermia and Intestinal Permeability: A Systematic Review
Pires, W., Veneroso, C. E., Wanner, S. P., Pacheco, D. A. S., Vaz, G. C., Amorim, F. T., Tonoli, C., Soares, D. D., & Coimbra, C. C. (2016) · Sports Medicine · doi:10.1007/s40279-016-0654-2 · Cited by 153
Rat intestinal mucosal responses to a microbial flora and different diets.
Sharma, R. P., Schumacher, U., Ronaasen, V., & Coates, M. (1995) · Gut · doi:10.1136/gut.36.2.209 · Cited by 151
The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
Seo, Y. S., & Shah, V. H. (2012) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2012.18.4.337 · Cited by 151
Ponziani, F. R., Zocco, M. A., Cerrito, L., Gasbarrini, A., & Pompili, M. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1481747 · Cited by 150
Self-citationAnti-inflammatory effects of nicotine in obesity and ulcerative colitis
Lakhan, S. E., & Kirchgessner, A. L. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-129 · Cited by 141
Addolorato, G., Ponziani, F. R., Dionisi, T., Mosoni, C., Vassallo, G. A., Sestito, L., Petito, V., Picca, A., Marzetti, E., Tarli, C., et al. (2020) · Liver International · doi:10.1111/liv.14383 · Cited by 135
Self-citationIncreased Gut Permeability and Bacterial Translocation after Chronic Chlorpyrifos Exposure in Rats
Condette, C. J., Khorsi‐Cauet, H., Morlière, P., Zabijak, L., Reygner, J., Bach, V., & Gay‐Queheillard, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102217 · Cited by 134
Keeping Bacteria at a Distance
Johansson, M., & Hansson, G. C. (2011) · Science · doi:10.1126/science.1213909 · Cited by 134
Basuroy, S., Sheth, P., Mansbach, C. M., & Rao, R. K. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00464.2004 · Cited by 134 · cited 1×
“Pretreatment with glutamine has been shown to be effective in reducing disassembly of occludin, ZO1, E-cadherin, and β-catenin in human colonic cells exposed to acetaldehyde [213].”
BackgroundGut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus
Ma, Y., Xu, X., Li, M., Cai, J., Wei, Q., & Niu, H. (2019) · Molecular Medicine · doi:10.1186/s10020-019-0102-5 · Cited by 128
Lowe, P., Gyöngyösi, B., Satishchandran, A., Iracheta‐Vellve, A., Ambade, A., Kodys, K., Catalano, D., Ward, D. V., & Szabó, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174544 · Cited by 124
Nielsen, L. N., Roager, H. M., Casas, M. E., Frandsen, H. L., Gosewinkel, U., Bester, K., Licht, T. R., Hendriksen, N. B., & Bahl, M. I. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2017.10.016 · Cited by 122
Leaky Gut and Autoimmunity: An Intricate Balance in Individuals Health and the Diseased State
Paray, B. A., Albeshr, M. F., Jan, A. T., & Rather, I. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249770 · Cited by 122
An Update Review on the Paneth Cell as Key to Ileal Crohn's Disease
Wehkamp, J., & Stange, E. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00646 · Cited by 116
Pappo, I., Becovier, H., Berry, E. M., & Freund, H. R. (1991) · Journal of Surgical Research · doi:10.1016/0022-4804(91)90078-z · Cited by 111
Ray, A. A., Cot, M., Puzo, G., Gilleron, M., & Nigou, J. (2012) · Biochimie · doi:10.1016/j.biochi.2012.06.007 · Cited by 109
Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase
Mullin, J. M., Valenzano, M. C., Whitby, M., LURIE, D., Schmidt, J., Jain, V., Tully, O., Kearney, K. R., Lazowick, D., Mercogliano, G., et al. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03824.x · Cited by 108
Martinsen, T. C., Fossmark, R., & Waldum, H. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236031 · Cited by 108
Fructose Induced Endotoxemia in Pediatric Nonalcoholic Fatty Liver Disease
Jin, R., Willment, A., Patel, S. S., Sun, X., Song, M., Mannery, Y. O., Kosters, A., McClain, C. J., & Vos, M. B. (2014) · International Journal of Hepatology · doi:10.1155/2014/560620 · Cited by 105
Treiber, G. M., Prietl, B., Fröhlich-Reiterer, E. E., Lechner, E., Ribitsch, A., Fritsch, M., Rami-Merhar, B. M., Steigleder‐Schweiger, C., Graninger, W. B., Borkenstein, M. H., et al. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.08.002 · Cited by 103
Zuo, L., Li, Y., Wang, H., Wu, R., Zhu, W., Zhang, W., Cao, L., Gu, L., Gong, J., Li, N., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.08.008 · Cited by 102
Subclinical gut inflammation in ankylosing spondylitis
Ciccia, F., Rizzo, A. G., & Triolo, G. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000239 · Cited by 101
Thim-uam, A., Surawut, S., Issara-Amphorn, J., Jaroonwitchawan, T., Hiengrach, P., Chatthanathon, P., Wilantho, A., Somboonna, N., Palaga, T., Pisitkun, P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57275-0 · Cited by 100
Contributions of intestinal epithelial barriers to health and disease
Choi, W., Yeruva, S., & Turner, J. R. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.036 · Cited by 96
Evolving trends in next-generation probiotics: a 5W1H perspective
Almeida, D., Machado, D., Andrade, J. C., Mendo, S., Gomes, A. M., & Freitas, A. C. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1599812 · Cited by 92
The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders
Losurdo, G., D’Abramo, F. S., Indellicati, G., Lillo, C., Ierardi, E., & Leo, A. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103531 · Cited by 91
Yang, Q., Ouyang, J., Sun, F., & Yang, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590685 · Cited by 90
Yang, P., He, S., & Zheng, P. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04710.x · Cited by 89
Hot Spices Influence Permeability of Human Intestinal Epithelial Monolayers
Jensen‐Jarolim, E., Gajdzik, L., HABERL, I., Kraft, D., Scheiner, O., & Graf, J. (1998) · Journal of Nutrition · doi:10.1093/jn/128.3.577 · Cited by 87
Cited by
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic
Porcari, S., Benech, N., Valles-Colomer, M., Segata, N., Gasbarrini, A., Cammarota, G., Sokol, H., & Ianiro, G. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.020 · Cited by 331
Self-citationIn Vitro Models of Biological Barriers for Nanomedical Research
Carton, F., & Malatesta, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168910 · Cited by 34
Unveiling The Therapeutic Potential of Probiotics: A Review
Tukaram, K. S., Sopanrao, S. R., & Kacharu, L. O. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2025.09.011 · Cited by 19
Metadata
- Authors
- Di Tommaso, N., Gasbarrini, A., & Ponziani, F. R.
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2021-12-06
- Volume
- 18
- Issue
- 23
- Pages
- 12836
- ISSN
- 1660-4601 (ISSN-L)
- OpenAlex
- W4200350756
- Cited by
- 533
- References
- 235
- FWCI
- 18.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.